Evidence map

ArticleFrontiers in oncology2022

Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis.

Dandan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36457493